INTERNET INVESTIGATIONAL DRUG INFORMATION SHOULD BE PRESENTED "CONSISTENTLY" TO ALL AUDIENCES, SEC TELLS FDA; RESTRICTING ACCESS APPEARS THORNY
Executive Summary
Investigational drug information released through the Internet should be presented in a consistent manner regardless of whether it is directed at financial, scientific/medical or consumer groups, Securities & Exchange Commission Division of Enforcement Special Counsel Al Rusch told an Oct. 16 FDA public meeting about the advertising and promotion of medical products on the Internet.